NanoViricides Inc. (NNVC)

[Rob_]

KMBJN,

Excellent posts today.

What do you think of NNVC buying Theracour and thereby getting full rights to the licenses, patents, etc as well as acquiring Theracour's current royalty of 15% on all "net sales" of viricides? Possible cost would be a 15-20% stake in NNVC for Theracour's share holders (mainly resulting in Diwan having an even greater stake in NNVC and thereby more fully aligning his interests with NNVC). At the buyout price, I don't think Diwan would lose much in terms of future wealth.

This would result in dilution for current shareholders of NNVC but eliminate some of the awkwardness and feelings of insecurity that come with the current structure. I think it would actually boost the current share price immediately. Diwan could still keep rights to all Theracour's technology for cancer treatment with nanomicelle technology.